Methods : This video shows the MRI/US Transperineal fusion guided prostate biopsy (MRUS_TPBx) procedure on a 72-year-old male with a medical history of an elevated prostate-specific antigen. A Multiparametric MRI showed suggestive images of malignant prostate lesions at the peripheral zones. The...
[18] Haffner J, Lemaitre L, Puech P, et al. Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection. BJU Int 2011;108:E171-8. [19] Kasivisvanathan V, Dufour R, Moore CM, et ...
Procedure-associated adverse events were recorded. Patient discomfort during both the local anesthesia and the biopsy procedure was determined using a visual analogic scale (0–10). Detection rates of grade group (GG) ≥2 prostate cancer and ...
Magnetic resonance imaging (MRI) is used to detect the prostate index lesion before targeted biopsy. However, the number of biopsy cores that should be obtained from the index lesion is unclear. The aim of this study is to analyze how many MRI-targeted biopsy cores are needed to establish th...
C. et al. How reliable is 12-core prostate biopsy procedure in the detection of prostate cancer? Can. Urol. Assoc. J. 7, E293–E298 (2013). PubMed PubMed Central Google Scholar Futterer, J. J. et al. Can clinically significant prostate cancer be detected with multiparametric magnetic ...
patients with advanced prostate cancer still lack effective treatment, so early diagnosis is particularly important. Although the diagnosis methods of prostate cancer are diverse, the gold standard for clinical diagnosis of prostate cancer is still prostate biopsy guided by transrectal ultrasound. With the...
An approach using MRI of the prostate followed by targeted biopsy (TB) in men with images suggesting a high risk beat the conventional approach of using transrectal ultrasound (TRUS)-guided 12-core systematic biopsy. The results come from the randomized phase 3 PRECISION trial, and werepublished...
Welcome to KOELIS Official website! Prostate cancer is the second most common cancer in men. In fact, about 1 in 7 men will be diagnosed with this disease during his lifetime.
up parameters comprised a series of functional and quality-of-life outcome measures along with regular PSA measurements, an MRI at 12 months and an assessment of histology with a systematic 12-core prostate biopsy at 12 months, and a further sys...
Re: Improving Detection of Clinically Significant Prostate Cancer: MRI/TRUS Fusion-guided Prostate Biopsy Introduction: There are limited data on the learning curve of magnetic resonance imaging/transrectal ultrasound (MRI/TRUS)-fusion targeted prostate biopsie... Arnauld,Villers - 《European Urology》 ...